Installé dans l’appartement où Louis Pasteur passa les sept dernières années de sa vie, le musée Pasteur constitue une occasion unique de pénétrer dans l’univers de l’illustre savant : de visualiser sa vie au quotidien aux côtés de son épouse et de traverser son œuvre scientifique abondante.
Faire un don à l’Institut Pasteur, c’est contribuer aux avancées de ses recherches biomédicales et être ainsi associé à ses chercheurs et à leurs découvertes sur les cancers, les maladies du cerveau, les maladies infectieuses, et bien d’autres encore…
La stratégie scientifique de l’Institut Pasteur s’appuie sur le développement de thématiques originales et innovantes, encourageant les échanges et la pluridisciplinarité des approches de recherche. Pour relever ce défi, l’Institut Pasteur met à la disposition de ses équipes les ressources technologiques indispensables à leur réactivité et à une recherche de haut niveau.
Le Centre médical de l’Institut Pasteur est un centre de santé conventionné secteur 1. Il propose une offre de soin à destination des voyageurs, et la prise en charge diagnostique et thérapeutique des maladies infectieuses, tropicales et allergiques. Le Centre médical de l’Institut Pasteur, engagé depuis 2008 dans la mise en place d’une démarche Qualité, est le premier centre de santé français à recevoir en janvier 2011 la certification qualité "AFAQ Centre de santé" de l'AFNOR Certification.
Depuis la création du premier cours de « microbie technique » en 1889, l’enseignement reste une priorité pour l’Institut Pasteur. Reconnu au niveau international, la qualité de l’enseignement de l’Institut Pasteur lui permet d’accueillir chaque année des étudiants venus du monde entier pour parfaire leur formation ou compléter leur cursus.
Presentation of the laboratory and its research topics:
The laboratory’s primary goal is to identify molecules, which are both implicated in parasite evasion of the host’s immune system and could ultimately be used as targets in the development of new therapies. The laboratory has been studying experimental models of human Chagas disease and animal trypanosomosis, two of the “most neglected diseases” that afflict the poor and powerless in developing regions of sub-Saharan Africa, Asia and the Americas. Chagas’ disease, the third largest disease burden in Latin America, is caused by Trypanosoma cruzi. The team has recently drawn its attention to other protozoan parasites of the trypanosomatid family which are equally considered as “neglected”: Leishmania (L) donovani and L. major, responsible respectively for visceral and cutaneous Leishmaniasis. The pathogenesis differs among those trypanosomatid infectious processes, reflecting the different interactions of these parasites with their hosts, but important immunological dysfunctions are involved in the development of these seriously disabling illnesses. Aiming at better exploring the well-established experimental models of infections we have further developed our strategies of study in order to decipher the more precisely as possible the interaction of these microorganisms with their hosts. To circumvent the major constraints inherent to studying parasite /host interactions in the field, we had both developed in vivo animal models of trypanosomosis (1-4) and leishmaniasis (5-7). Our team uses a highly interdisciplinary approach to generate and validate innovative tools for real time imaging of these Trypanosomatidae in their mammalian hosts and insect vectors. We showed that the rodent experimental model reproduce most features of the infection in human. More than reflecting only the main parasitological parameters of the animal infection, the rodent model can be used to elucidate the immunopathological mechanisms involved in parasite evasion and persistence, and the tissue damage seen during infection and disease.
Description of the project:
(1 page, Arial font size 11 : 600 words in total with at least 50% dedicated specifically to the proposed PhD project(s))
During the infectious cycle, trypanosomatid pathogens of the genus Leishmania alternate between the insect promastigote stage and the vertebrate amastigote stage that proliferates inside infected host tissues provoking the pathology of the disease (5). The major scope of our work is to accurately delineate and characterize Trypanosomatidae-driven processes in rodent tissues following parasite inoculation. The small size of these eukaryotic parasites and the spatial resolution limits of conventional imaging technologies have hampered analysis of host-parasite interactions at the single cell level. We have previously established and validated innovative imaging technologies to visualize tissue localization dynamics of Leishmania and Trypanosoma in vertebrate hosts (5). We built upon our expertise in cutting edge imaging and cellular host interactions to develop and use bioluminescence/fluorescence quantitative imaging with 2D and 3D spatial resolution (8, 9). By using bioluminescent and/or far red fluorescent parasites, we investigated the possibility to delineate the various phases of the infectious process by monitoring the Leishmania populations and analyzing the cellular mechanisms at the host and tissue (7, 9).
Monitoring of Leishmania donovani in laboratory rodents
The objective of the proposed project is primarily to monitor disease progression by examining host-parasite interactions over time and in the three-dimensional space of living mice and analyse the early steps of the infection. Secondly, the goal is to test the hypothesis that a correlation may exist between the virulence of L. donovani and the B- cell function thus favoring the mechanisms of parasite escape of T cell responses implemented by the host. In order to monitor the early development and dissemination of L. donovani at the inoculation site in mouse dermis after inoculation, a panel of intravital imaging technologies will be used to visualize the infection process. Animals infected by bioluminescent/fluorescent parasites will be alternatively observed by epifluorescence microscopy, optical fiber, two-photon and spinning-disk laser scanning microscopy, widefield Apotome confocal microscopy and IVIS Spectrum imaging system. The next exciting step will be to monitor the infection in vivo and especially to understand the early steps of the infection (parasite migration, proliferation, differentiation, interaction with host cells …).
Parameters that account for the establishment of parasites in mice will be determined in real time during the phase of parasite implantation and expansion. We will use an innovative approach for monitoring and measuring simultaneously parasite load and immune responses (9) after inoculation of L. donovani. A main limitation for in vivo studies of experimental visceral leishmaniasis is the loss of L. donovani virulence in culture. In order to correlate expression of virulence with infectivity and pathogenicity “virulent” and “attenuated” bioluminescent L. donovani will be used to generate new transgenic parasites over-expressing factors previously demonstrated to be important for the survival of L. donovani amastigotes in the liver and the spleen (10). Several candidates will be chosen as candidate virulence/survival factors that will be over-expressed in virulent and attenuated parasites to establish transgenic lines with distinct virulence phenotypes. Evaluation of the survival and expansion of these parasites will be performed by monitoring bioluminescent parasite burden in macrophages and in hamsters. By using a hamster model as part of a proof-of-principle study we will be able testing the ability of luciferase-expressing L. donovani to cause visceral leishmaniases (VL) following various clinical signs of the disease, including fever, pallor, wasting, and hepato-splenomegaly. These quantitative imaging studies will open up possibilities to analyze infectious processes in mice after inoculation of “virulent” and “attenuated” L. donovani. The parasite size populations, humoral and T cell responses will be studied in vivo and ex-vivo during the different phases of the infection. The investigation of the cellular mechanisms at the host and tissue levels with high temporal and/or spatial resolution will contribute to the elucidation of the dynamics of intracellular trafficking events The resulting data obtained in this work will greatly enhance our understanding of leishmaniasis pathogenic process, and provide a major breakthrough in anti-parasitic research.
1. N. Chamond et al., PLoS Negl Trop Dis4, e792 (2010).
2. S. D'Archivio et al., PLoS Negl Trop Dis5, e1461 (Dec, 2011).
3. S. D'Archivio et al., PLoS Negl Trop Dis7, e1976 (Jan, 2013).
4. S. Goyard et al., Parasitol Int, (Jul 25, 2013).
5. T. Lang, H. Lecoeur, E. Prina, Trends Parasitol25, 464 (Oct, 2009).
6. E. Giraud et al., PLoS Negl Trop Dis6, e1980 (Dec, 2012).
7. E. Giraud et al., Parasitol Int, (Aug 31, 2013).
8. H. Lecoeur et al., Microbes Infect12, 46 (Jan, 2010).
9. E. de La Llave et al., Cell Microbiol13, 81 (Jan, 2011).
10. P. Pescher, T. Blisnick, P. Bastin, G. F. Spath, Cell Microbiol, (Mar 23, 2011).
Keywords: Leishmania donovani, real time imaging, RT-qPCR, virulence, rodents, experimental animal model,